Article Type
Changed
Mon, 03/04/2019 - 13:33
Display Headline
Aggressive blood pressure lowering is safe, but benefit is still hard to prove
The Hypertension Optimal Treatment trial
Article PDF
Author and Disclosure Information

Donald G. Vidt, MD
Senior physician, Department of Nephrology/Hypertension, Cleveland Clinic; professor of internal medicine, Ohio State University; member, Sixth Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure

Marc A. Pohl, MD
Department of Nephrology/Hypertension, Cleveland Clinic; investigator, Hypertension Optimal Treatment Trial*

Address: Donald G. Vidt, MD, Department of Nephrology/Hypertension, A101, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

*The Hypertension Optimal Treatment trial was sponsored by Astra AB, Sweden; Astra Merck Inc., USA; and Hoechst, Argentina.

Issue
Cleveland Clinic Journal of Medicine - 66(2)
Publications
Page Number
105-111
Sections
Author and Disclosure Information

Donald G. Vidt, MD
Senior physician, Department of Nephrology/Hypertension, Cleveland Clinic; professor of internal medicine, Ohio State University; member, Sixth Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure

Marc A. Pohl, MD
Department of Nephrology/Hypertension, Cleveland Clinic; investigator, Hypertension Optimal Treatment Trial*

Address: Donald G. Vidt, MD, Department of Nephrology/Hypertension, A101, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

*The Hypertension Optimal Treatment trial was sponsored by Astra AB, Sweden; Astra Merck Inc., USA; and Hoechst, Argentina.

Author and Disclosure Information

Donald G. Vidt, MD
Senior physician, Department of Nephrology/Hypertension, Cleveland Clinic; professor of internal medicine, Ohio State University; member, Sixth Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure

Marc A. Pohl, MD
Department of Nephrology/Hypertension, Cleveland Clinic; investigator, Hypertension Optimal Treatment Trial*

Address: Donald G. Vidt, MD, Department of Nephrology/Hypertension, A101, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

*The Hypertension Optimal Treatment trial was sponsored by Astra AB, Sweden; Astra Merck Inc., USA; and Hoechst, Argentina.

Article PDF
Article PDF
The Hypertension Optimal Treatment trial
The Hypertension Optimal Treatment trial
Issue
Cleveland Clinic Journal of Medicine - 66(2)
Issue
Cleveland Clinic Journal of Medicine - 66(2)
Page Number
105-111
Page Number
105-111
Publications
Publications
Article Type
Display Headline
Aggressive blood pressure lowering is safe, but benefit is still hard to prove
Display Headline
Aggressive blood pressure lowering is safe, but benefit is still hard to prove
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media